3
2
↑3
↓0
—2
Evidence suggests Magnesium mayincreaseMood.
7 studies (5 claims)
Emerging evidence
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| a formulation containing cannabidiol (CBD; 35 mg), cannabigerol (CBG; 50 mg), beta caryophyllene (BCP; 25 mg), branched-chain amino acids (BCAAs; 3.8 g), and magnesium citrate (420 mg) | No effect - There was no significant effect | mood disturbance | Human | exercise-trained individuals | 35 mg CBD (combined with CBG, BCP, BCAAs, and magnesium citrate) | A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS).cited 9× |
| active treatment comprising a daily dose of 1125 mg eicosapentaenoic acid, 441 mg docosahexaenoic acid, 330 mg magnesium and 7.5 mg vitamin E | No effect - will be randomised to | validated questionnaires and tablet-based tasks sensitive to mood | Human | healthy university students experiencing non-clinical levels of anxiety and depression | 1125 mg eicosapentaenoic acid, 441 mg docosahexaenoic acid, 330 mg magnesium, and 7.5 mg vitamin E daily. | The effects of a high eicosapentaenoic acid multinutrient supplement on measures of stress, anxiety and depression in young adults: Study protocol for NutriMOOD, a randomised double-blind placebo-controlled trial.cited 1× |
| magnesium compounds | Increases - have been confirmed by the results of numerous pre-clinical and clinical studies | mood-improving potential | HumanAnimal | — | Not specified | Magnesium and depression.cited 46× |
| vitamin D plus magnesium supplementation | Increases - has beneficial influences | mood | Human | obese women with mild to moderate depressive symptoms | — | Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms.cited 21× |
| vitamin D and magnesium co-supplementation | No effect - test the effects | mood | Human | obese women | — | Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.cited 16× |
| magnesium | No effect - evaluate the individual effects | mood | Human | 108 obese women | — | Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.cited 16× |
| magnesium-L-threonate | No effect - did not show improvement | mood | Human | patients who underwent breast cancer procedure | Not specified in the abstract. | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery.cited 1× |